Navigation Links
How Cervical Cancer Vaccines Came to Be
Date:1/18/2013

By Serena Gordon
HealthDay Reporter

FRIDAY, Jan. 18 (HealthDay News) -- The cervical cancer vaccine has turned into one of the biggest success stories in the field.

Although almost a half-million women develop cervical cancer annually, health experts predict that number is likely to drop dramatically in the coming years because of two vaccines that can prevent many cases of the disease.

It wasn't until the 1980s that researchers confirmed that most cases of cervical cancer were caused by the human papillomavirus (HPV). The most common sexually transmitted virus, HPV has more than 40 different strains that can affect the genital area, according to the U.S. Centers for Disease Control and Prevention. Most people who are infected with HPV never know they've been infected.

"After the agent that causes cervical cancer was found to be HPV, the idea for a vaccine was obvious to many," said Dr. Alfred Saah, director of vaccines clinical research for Merck and Co., in Whitehouse Station, N.J. "The question then became which part of the virus was related to immunity and would be the best part of the virus to make a vaccine."

Saah said that work began in earnest in the early 1990s on cloning the relevant parts of the virus strains that would be needed for an effective vaccine. To prevent cervical cancer, the vaccine would need to teach the immune system to recognize the human papillomavirus cells so that it would respond by destroying those cells.

"The vaccine stimulates the body's immune system in several ways so that when the host is exposed to natural HPV, the immune system is ahead of the virus and neutralizes the virus before infection and disease can occur," Saah explained.

Once a potential vaccine was created, tests in animals showed it worked extremely well. Then, the vaccine had to pass phase 1 clinical trials in humans, which had to demonstrate that the vaccine causes the body's immune system
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Research makes connetion between tubal ligation and increase in cervical cancer rates
2. Cervical cancer screening in less-developed areas should be tailored to local conditions
3. New test may improve cervical cancer detection
4. Cervical cancer and pre-cancer cervical growths require single HPV protein
5. Cervical Disease Treatment Not Linked to Premature Birth Risk
6. Women With HIV May Not Have Higher Cervical Cancer Risk: Study
7. HIV-infected women do not appear to be at increased risk of cervical cancer
8. HPV testing in HIV-positive women may help reduce frequent cervical cancer screening
9. Lack of insurance linked to advanced stage cervical cancer
10. Cervical Cancer Spotted Later in Women Without Health Insurance
11. Simple assault and ground level fall do not require cervical spine CT
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How Cervical Cancer Vaccines Came to Be
(Date:3/4/2015)... (PRWEB) March 04, 2015 When people talk ... the top artists spread across numerous genres, the Houston ... the conversation. Each night during the annual livestock show and ... addition to the other activities being held at the event. ... groups of performers that will try and get the festival ...
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... Falls Church, VA (PRWEB) March 04, 2015 ... in Four Hours , **FDAnews Webinar**, March 24, 2015 ... , FDA investigators generally know within four hours ... not. If the manufacturer is on their “good” list, ... they’re doing. If a manufacturer is on the “bad” ...
(Date:3/4/2015)... The ability of volumetric breast imaging ... help improve breast cancer risk prediction models is ... at the European Congress of Radiology (ECR) meeting, ... posters and 2 session presentations - highlight the ... quantitative breast imaging software tools to provide insight ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 With the growing ... the lives of our teens and young adults, combined with ... difficult and confusing to try to keep up with what ... fad or trend is replaced on a daily basis. , ... substances, and the slang that is used to discreetly talk ...
Breaking Medicine News(10 mins):Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2
... Ind. - A Purdue University research team developed a ... as needed for extending the shelf life of foods ... an assistant professor of food science, altered the surface ... which led to the creation of several forms of ...
... health concerns about increasing antiviral resistance among certain influenza ... alternative antiviral treatment options. The findings are published in ... Infectious Diseases . (Please see below for links to ... two classes of drugs: M2 blockers (adamantanes) and neuraminidase ...
... has contributed to a study showing that a low dose ... study is published in today,s Lancet . , ... Rothwell in Oxford, and is based on an overview of ... with reducing heart attacks, but have also gathered information on ...
... , MONDAY, Dec. 6 (HealthDay News) -- Long-term ... of dying from a wide array of cancers, a new ... that a low-dose aspirin (75 milligrams) taken daily for at ... percent drop in fatalities depending on the type of cancer. ...
... Physical Therapy Association (APTA) is pointing to a new study ... to encourage the newly established Center for Medicare and Medicaid ... to physical therapist services that was recommended in the recent ... Spine , showed Medicare patients who received physical therapy ...
... HealthDay Reporter , MONDAY, Dec. 6 (HealthDay News) -- Applying sunscreen ... chances of getting melanoma by half, a new study has found. ... 25 to 75 into two groups. One group was told to ... for five years between 1992 and 1996. The other group was ...
Cached Medicine News:Health News:Nanoparticle gives antimicrobial ability to fight Listeria longer 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 3Health News:Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 2Health News:Daily Aspirin Linked to Steep Drop in Cancer Risk 2Health News:Daily Aspirin Linked to Steep Drop in Cancer Risk 3Health News:Early physical therapy for low back pain associated with less subsequent health care utilization 2Health News:Daily Sunscreen Use Does Protect from Melanoma, Study Finds 2Health News:Daily Sunscreen Use Does Protect from Melanoma, Study Finds 3
(Date:3/4/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... II proof of concept clinical study investigating the ... in the treatment of chronic pruritus in patients ... clinically meaningful improvement from baseline by tradipitant (40.5mm ... 100mm unit Visual Analog Scale (VAS) for itch, ...
(Date:3/4/2015)... China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or ... in China, today announced its financial results for the ... Fourth Quarter 2014 Financial Highlights , Total ... 36.2%, or 36.8% excluding the impact of foreign currency ... in the same quarter of 2013. , Gross ...
(Date:3/4/2015)... GSI Group Inc. (NASDAQ: GSIG ... and supplier of precision photonics and motion control components ... technology markets, today reported financial results for the fourth ... financial results in this press release are GAAP measures ... fourth quarter of 2014, GSI generated revenue of $94.0 ...
Breaking Medicine Technology:Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9
... Aug. 28 Intercell AG (VSE: ICLL) today,announced ... initiated a Phase II,clinical trial of V710, an ... aureus) infections. This randomized double blind,placebo controlled study ... vaccine candidate in patients with end-stage kidney disease ...
... Prevent ... Onset of Parkinson,s Disease, CHICAGO, Aug. 27 The British ... made a crucial breakthrough in the battle to slow or prevent ... The researchers have genetically produced the first ever mouse model,with ...
Cached Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: